Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

NCT00002565 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
DRUG: CHOP regimen
DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: idarubicin
DRUG: ifosfamide
DRUG: mesna
DRUG: methylprednisolone
DRUG: mitoxantrone hydrochloride
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]